3i_FW
Report_NN
and_PHC
accounts_NN
2004_CD
Ten_CD
largest_JJ
investments_NOMZ
At_PIN
31_CD
March_NN
2004_CD
,_,
the_DT
Directors_NN
valuation_NOMZ
of_PIN
the_DT
ten_NN
largest_JJ
investments_NOMZ
was_VBD [BEMA]
a_DT
total_NN
of_PIN
557_CD
million_CD
._.
First_RB
in_PIN
1_CD
1_CD
2_CD
3_CD
3_CD
invested_VBN
Cost_NN
of_PIN
equity_NOMZ
valuation_NOMZ
the_DT
year_NN
Net_JJ
assets_NN
Earnings_GER
Investment_NOMZ
in_PIN
m_NN [PASS]
shares_NN
held_VBD [PRIV]
m_FW
m_FW
m_FW
m_FW
SR_FW
Technics_NN
Holding_GER
AG_NN
2002_CD
Technical_NN
solutions_NOMZ
provider_NN
for_PIN
commercial_JJ
aircraft_NN
fleets_NN
Equity_NOMZ
shares_NN
6_CD
32.2_CD
%_NN
45_CD
Loans_NN
32_CD
32_CD
2_CD
38_CD
77_CD
2_CD
6_CD
2_CD
Fonecta_NN
Group_NN
Oy_NN
2002_CD
Directory_NN
services_NN
Equity_NOMZ
shares_NN
4_CD
33.5_CD
%_NN
67_CD
Loans_NN
2_CD
4672152_CD
4_CD
Betapharm_NN
Arzneimittel_NN
GmbH_NN
2003_CD
Supplier_NN
of_PIN
generic_JJ
prescription_NOMZ
drugs_NN
Equity_NOMZ
shares_NN
3_CD
66.2_CD
%_NN
3_CD
Loans_NN
61_CD
61_CD
64_CD
64_CD
Westminster_NN
Health_NN
Care_NN
Holdings_GER
Ltd_NN
2002_CD
Care_NN
homes_NN
operator_NN
Equity_NOMZ
shares_NN
1_CD
49.6_CD
%_NN
20_CD
2_CD
Loans_NN
37_CD
37_CD
3_CD
38_CD
57_CD
5_CD
6_CD
4_CD
5_CD
Travelex_NN
Holdings_GER
Ltd_NN
1998_CD
Foreign_JJ
currency_NN
services_NN
Equity_NOMZ
shares_NN
19.6_CD
%_NN
57_CD
57_CD
45_CD
15_CD
fide_NN
Telefoongids_NN
Holding_GER
BV_NN
2002_CD
Directory_NN
services_NN
Equity_NOMZ
shares_NN
8_CD
22.1_CD
%_NN
40_CD
Loans_NN
15_CD
15_CD
1_CD
23_CD
55_CD
1_CD
30_CD
3_CD
6_CD
ERM_NN
Holdings_GER
Ltd_NN
2001_CD
Environmental_NN
consultancy_NN
Equity_NOMZ
shares_NN
38.1_CD
%_NN
15_CD
Loans_NN
32_CD
32_CD
2_CD
32_CD
47_CD
2_CD
4_CD
2_CD
Pets_NN
at_PIN
Home_NN
Group_NN
Ltd_NN
1995_CD
Retailer_NN
of_PIN
pets_NN
and_PHC
pet_NN
supplies_NN
Equity_NOMZ
shares_NN
2_CD
26.0_CD
%_NN
21_CD
Loans_NN
25_CD
25_CD
2_CD
27_CD
46_CD
2_CD
18_CD
18_CD
Williams_NN
Lea_NN
Group_NN
Ltd_NN
1965_CD
Outsourced_NN
print_NN
services_NN
Equity_NOMZ
shares_NN
33_CD
38.1_CD
%_NN
45_CD
33_CD
45_CD
39_CD
4_CD
Malmberg_NN
Investments_NOMZ
BV_NN
2001_CD
Educational_NN
publisher_NN
Equity_NOMZ
shares_NN
7_CD
41.8_CD
%_NN
24_CD
Loans_NN
18_CD
18_CD
1_CD
25_CD
42_CD
1_CD
16_CD
Notes_NN
1_CD
The_DT
investment_NOMZ
information_NOMZ
is_VPRT [BEMA]
in_PIN
respect_NN
of_PIN
the_DT
Groups_NN
holding_VBG [PRIV] [WZPRES]
and_PHC
excludes_VPRT
any_QUAN
co-investment_NOMZ
by_PIN
3i_NN
managed_VBD
funds_NN
._.
2_CD
Income_NN
in_PIN
the_DT
year_NN
represents_VPRT
dividends_NN
received_VBD
inclusive_JJ
of_PIN
any_QUAN
overseas_PLACE
withholding_GER
tax_NN
and_CC
gross_JJ
interest_NN
receivable_NN
in_PIN
the_DT
year_NN
to_PIN
31_CD
March_NN
2004_CD
._.
3Net_JJ
assets_NN
and_PHC
earnings_GER
figures_NN
are_VPRT [PASS]
taken_VBN
from_PIN
the_DT
most_EMPH
recent_JJ
audited_JJ
accounts_NN
of_PIN
the_DT
investee_NN
business_NOMZ
._.
The_DT
figures_NN
shown_VBN [PRIV] [WZPAST]
are_VPRT [BEMA]
the_DT
total_JJ
earnings_GER
and_CC
net_JJ
assets_NN
of_PIN
each_QUAN
business_NOMZ
._.
Because_CAUS
of_PIN
the_DT
varying_VBG
rights_NN
attaching_VBG [WZPRES]
to_PIN
the_DT
classes_NN
of_PIN
shares_NN
held_VBN [PRIV] [WZPAST]
by_PIN
the_DT
Group_NN
,_,
it_PIT
could_POMD
be_VB
misleading_VBG
to_TO
attribute_VB
a_DT
certain_JJ
proportion_NOMZ
of_PIN
earnings_GER
and_CC
net_JJ
assets_NN
to_PIN
the_DT
proportion_NOMZ
of_PIN
equity_NOMZ
capital_NN
held_VBN [PRIV]
._.
Negative_JJ
earnings_GER
and_CC
net_JJ
assets_NN
are_VPRT [PASS]
shown_VBN [PRIV]
in_PIN
brackets_NN
._.
4_CD
Betapharm_NN
Arzneimittel_NN
GmbH_NN
was_VBD [PASS]
incorporated_VBN
in_PIN
2003_CD
and_CC
no_SYNE
audited_JJ
accounts_NN
are_VPRT [BEMA]
available_PRED
,_,
consequently_CONJ
no_SYNE
net_JJ
assets_NN
or_CC
earnings_GER
are_VPRT [PASS]
disclosed_VBN [PUBV]
._.
5_CD
The_DT
cost_NN
of_PIN
the_DT
equity_NOMZ
held_VBN [PRIV] [WZPAST]
in_PIN
Travelex_NN
Holdings_GER
Ltd_NN
is_VPRT [BEMA]
121,000_CD
._.
6_CD
The_DT
cost_NN
of_PIN
the_DT
equity_NOMZ
held_VBN [PRIV] [WZPAST]
in_PIN
ERM_NN
Holdings_GER
Ltd_NN
is_VPRT [BEMA]
398,000_CD
._.
